The University Hospital Center of Oran, Algeria, is hosting the 4th International Days of Medical Biochemistry from October 12-13, 2026. The event, organized by the hospital's biochemistry department under the supervision of Professor Nashi Murad, brings together experts and researchers from various national health and research institutions. They will discuss the latest scientific developments in biological diagnosis and care for rare and chronic diseases.
The scientific program, which spans two days, includes four training workshops and four scientific sessions. These sessions will cover topics related to recent advances in medical practice, including oncology and diseases of genetic origin. The event aims to promote the exchange of knowledge and experiences, as well as keep up with technological and scientific developments in medical biochemistry and molecular biology.
Professor Nashi Murad emphasized that the event provides an opportunity for experts to share experiences and learn about modern approaches to disease diagnosis and care. The sessions will also cover advances in emergency biological tests and innovative biomarkers. The goal is to improve diagnosis accuracy and develop patient care methods.
Rare diseases and genetic disorders are a major focus of discussion during these scientific days. The challenges of diagnosis and medical care for these conditions are significant. Professor Murad highlighted efforts to expand the list of rare diseases and develop a national plan for their care, similar to the national cancer control plan.
A project to establish a specialized unit for early detection of certain diseases in newborns is underway. This unit will conduct screening tests after birth, such as detecting congenital hypothyroidism, allowing for timely intervention and reducing potential complications.
One of the event participants noted that rare diseases pose a significant challenge to public health. Recent advances in high-throughput genetic sequencing technologies have enabled the diagnosis of many diseases that were previously undetectable. These technologies have increased diagnosis rates to 40-50% in some cases, particularly for rare diseases and neurodevelopmental disorders.
The event reflects the importance of investing in biotechnology and developing diagnostic capabilities. The discussions and presentations will help improve diagnosis and care for patients with rare and chronic diseases. The 4th International Days of Medical Biochemistry and the 1st International Days of the Research Laboratory in Medical Biochemistry and Molecular Biology will contribute to enhancing cooperation and knowledge sharing among experts in the field.
Key points
- Experts gather in Oran to discuss advances in medical biochemistry and molecular medicine
- Rare diseases and genetic disorders are a major focus of discussion during the event
- The event aims to promote the exchange of knowledge and experiences in medical biochemistry and molecular biology
